Atrial Arrhythmia Management with Sensor Controlled Atrial Refractory Period and Automatic Mode Switching in Patients with Minute Ventilation Sensing Dual Chamber Rate Adaptive Pacemakers

Although a long postventricular atrial refractory period fPVARP) may prevent the occurrence of pacemaker mediated tachycardias and inadvertent tracking of atrial arrhythmias in dual chamber (DDD) pacing, the maximum upper rate will necessarily be compromised. We tested the feasibility of using minute ventilation sensing in a dual chamber rate adaptive pacemaker (DDDR) to shorten the PVARP during exercise in 13 patients with bradycardias (resting PVARP = 463 ± 29 msec) to avoid premature upper rate behavior. Graded treadmill exercise tests in the DDD and DDDR modes at this PVARP resulted in maximum ventricular rates of 98 ± 8 and 142 ± 3 beats/min, respectively (P < 0.0001), due to chronotropic incompetence and upper rate limitation in the DDD mode, both circumvened with the use of sensor. In order to simulate atrial arrhythmias, chest wall stimulation was applied for 30 seconds at a rate of 250 beats/min at a mean unipolar atrial sensitivity of 0.82 mV. Irregular ventricular responses occurred in the DDD mode fthe rates at a PVARP of 280 and 463 ± 29 msec were, respectively 92 ± 5 and 66 ± 3 msec; P < 0.0001). In the DDDR mode at a PVARP of 463 ± 29 msec, regular ventricular pacing at 53 ± 2 beats/min occurred due to mode switching to VVIR mode in the presence of repetitive sensed atrial events within the PVARP. One patient developed spontaneous atrial fibrillation on follow-up, which was correctly identified by the pacemaker algorithm, resulting in mode switch from DDDR to regular VVIR pacing and preservation of rate response. In conclusion, sensor controlled PVARP allows a long PVARP to be used at rest without limiting the maximum rate during exercise. In addition, to offer protection against retrograde conduction, a long PVARP and mode switching also limit the rate during atrial arrhythmias and allow regular ventricular rate responses according to the physiological demands.     

Is Automatic Mode Switching Effective for Atrial Arrhythmias Occurring at Different Rates? A Study of the Efficacy of Automatic Mode and Rate Switching to Simulated Atrial Arrhythmias by Chest Wall Stimulation

Automatic mode switching (AMS) is a useful means to avoid rapid ventricular response during atrial fibrillation (AF), but AMS cannot occur if the detected atrial rate during AF is below the mode switching criteria. This may be the result of antiarrhythmic medications, or when the atrial events fall within the atrial blanking period, or if the atrial amplitudes during AF are too small to be sensed. We hypothesize that the addition of an automatic rate switching (ARS) algorithm may complement AMS response during AF with different detected atrial rates. We studied the Marathon DDDR pacemaker (Model 294-09, Intermedics Inc.) with the AMS and ARS algorithms that are independently programmable but can also operate in combination. AF sensed above the AMS rate (160 beats/min) will lead to VDIR pacing, whereas AF below AMS rate will be tracked at an interim rate as dictate by the ARS, at a ventricular response that is 20 beats/min above the sensor indicated rate. Atrial tachyarrhythmias were simulated by chest wall stimulation (CWS). CWS was applied to 33 patients (16 men, 17 women, mean age 69 +/- 11 years) with a Marathon DDDR pacemaker using an external pacer to simulate AF occurring at two rate levels: above the AMS rate (programmed at 160 beats/min) at 180 beats/min and below the AMS rate at 120 beats/min. The maximum, minimum, and mean ventricular rates during CWS in DDDR mode with AMS alone, ARS alone, and their combination were compared. During CWS at 120 beats/min, the AMS plus ARS setting showed a mean ventricular rate of 79 +/- 3 beats/min and 124 +/- 14 beats/min in the AMS setting alone (P < 0.01). With CWS at 180 beats/min, the mean ventricular rate in the AMS plus ARS setting compared to the AMS setting alone was not significantly different. However, the variation in ventricular pacing rate was 7 +/- 14 beats/min in the AMS plus ARS setting and 40 +/- 42 beats/min in the AMS setting (P < 0.05). In conclusion, AMS is effective for simulated atrial tachyarrhythmias sensed above the AMS rate. Combined AMS with ARS is useful to handle simulated atrial tachyarrhythmia at a slower rate and to avoid rate fluctuation during AMS. There is also a possibility that this can be applied to the naturally occurring atrial tachyarrhythmias.     

Importance of Heart Rate Response During Exercise in Patients Using Atrioventricular Synchronous and Ventricular Pacemakers

Atrioventricular synchronous pacing offers advantages over fixed-rate ventricular (VVI) pacing both at rest and during exercise. This study compared the hemodynamic effects at rest and exercise of ventricular pacing at a rate of 70 beats/min, ventricular pacing where the rate was increased during exercise and dual chamber pacing. Ten patients, age 63 +/- 8 years, with multiprogrammable DDD pacemakers were studied using supine bicycle radionuclide ventriculography. Radionuclide data during dual chamber pacing was acquired at rest and during a submaximal workload of 200-400 kpm/min. The pacemakers were then programmed to VVI pacing at a rate of 70 beats/min, and 1 week later, studies were repeated in the VVI mode at rest, during exercise at a rate of 70 beats/min, and during exercise with the VVI pacemaker programmed to a rate adapted to the DDD pacing exercise rate. At rest, the cardiac output was lower in the VVI compared with the AV sequential mode (4.1 +/- 1.1 vs 5.7 +/- 1.1 1/min, P less than 0.01). During exercise, the cardiac output increased from resting values in the DDD and VVI pacing modes, however cardiac output in the rate-adapted VVI mode was higher than in the VVI mode with the rate maintained at 70 beats/min (8.1 +/- 1.5 vs 6.3 +/- 1.1 1/min, P = 0.02). Three patients completed lower workloads with VVI pacing at 70 beats/min compared with AV synchronous pacing. At rest, AV sequential pacing was superior to VVI pacing, suggesting the importance of the atrial contribution to ventricular filling. With VVI pacing during exercise, cardiac output was improved with an increased pacemaker rate, suggesting that the heart rate response during exercise was the major determinant of the higher cardiac output.     

Magnet Application, a Cause of Persistent Arrhythmias in Physiological Pacemakers. Report of 2 Cases

Report of 2 cases. Magent application during routine pacemaker check-up induced persistent arrhythmias in two patients with physiological pacemakers. One patient had received an atrial synchronous ventricular demand pacemaker (VDD) because of alternating second-and third-degree atrio-ventricular block. During routine pacemaker follow-up, a magnet was applied over the pulse generator to measure the pacemaker rate. This converted the system to fixed rate ventricular pacing at a rate of 65 bpm which resulted in retrograde atrial activation. When the magnet was removed the retrograde conducted P-waves were sensed by the atrial amplifier and the ventricular output was triggered again, causing a re-entry pacemaker tachycardia with a rate of 175 bpm. The tachycardia could be suppressed by applying a magnet once more, but the pulse generator had to be programmed in the VVI-mode to prevent induction of the tachycardia again. A second patient had complete atrioventricular block and left heart failure. After three years of ventricular demand pacing, we decided to implant a DDD pacemaker because of persisting left heart failure and poor exercise tolerance. During a routine visit io the pacemaker clinic a magnet was applied over the pulse generator to measure the basic rate. The system was thus converted to fixed rate A-V-sequential pacing (DOO) which resulted in atrial flutter. When the magnet was removed and the pulse generator returned to its DDD mode, the atrial flutter was partially sensed by the atrial amplifier, resulting in a tachycardia with a variable rate up to 125 bpm. Fortunately we were able to terminate the atrial arrhythmia by applying the magnet again. In this patient fixed rate underdrive pacing stopped the atrial arrhythmia. (PACE, Vol. 5, September-October, 1982)     

A New Feature for Control of Inappropriate High Rate Tracking in DDDR Pacemakers

LEE, M.T., ET AL. A New Feature for Control of Inappropriate High Rate Tracking in DDDR Pacemakers. A limitation of current DDD and DDDR pacemakers is the inability to distinguish between inappropriate high rate atrial sensed events that are physiologically appropriate to track (e.g., elevated sinus rates resulting from exercise, emotional responses, etc.) and those that are physiologically inappropriate to track (e.g., paroxysmal atrial dysrhythmias, myopotentials, retrograde conduction, etc.). The sophistication of sensing circuitry is not yet sufficiently advanced to permit a pacemaker to distinguish appropriate atrial events by morphology. The addition of an independent sensor to a DDD pacemaker (i.e., DDDR) gives more information about the patient's condition, especially with respect to exercise. This information can be used to judge the appropriateness of a high sensed atrial rate, and to modulate the pacemaker's response. If the sensor input is below a specified level, indicating lack of exercise, the DDDR can track sensed atrial events only to a tolerably low limit-the conditional ventricular tracking limit (CVTL). Wenckebach-type behavior ensues at the CVTL until the sensor input increases, indicating that exercise is occurring, or until the sensed atrial rate decreases. If the sensor input indicates exercise, the DDDR pacemaker can track up to the programmed maximum rate. Two DDDR systems have been developed that incorporate this feature; one based on temperature, the other on activity. Currently the CVTL is set at a value about 30 ppm above the pacing rate, as a compromise to support emotional needs not seen by the sensor. Improved sensors could cause the decision to raise the tracking limit (i-e., recognition of physiological need for higher rates) to be more accurate, perhaps making the CVTL proportional to the sensor signal.     

Apparent Extension of the Atrioventricular Interval Due to Sensor-Based Algorithm Against Supraventricuiar Tachyarrhythmias

Rapid ventricular tracking response to supraventricular tachyarrhythmia is one major limitation to DDD pacing. In a DDDR pacemaker, sensor-based algorithms have been used to control these arrhythmias. These include the use of an interim rate limit (conditional ventricular tracking limit) or a separate maximum tracking and sensor rate limits (discrepant upper rate). These algorithms limit inappropriate ventricular pacing rate during tracking of pathological supraventricuiar tachyarrhythmia and atrial flutter by Wenckebach-like prolongation of the AV interval. We observed that this may cause an unexpected extension of the AV interval in patients with high atrial rate and intact AV nodal conduction. This was due to P wave rate above the conditional ventricular tracking limit or maximum tracking limit, but AV paced interval prolongation was avoided by the occurrence of intrinsic conduction, albeit at an AV interval longer than the programmed AV interval. This might appear as failure of ventricular pacing on the ECG. This phenomenon is a modified form of "upper rate" behavior occurring in the AV interval, and should be recognized as a normal behavior rather than pacemaker malfunction.     

A New Pacemaker for Paroxysmal Atrial Fibrillation Treated with Radiofrequency Ablation of the AV Junction

Atrial fibrillation is a relative contraindication to atrial synchronous pacing because of the risk of the tracking of rapid atrial rhythms by the pacemaker. In this study, we describe the clinical results of an AV synchronous rate responsive pacemaker with an original algorithm, which is able to sense pathological increments in atrial rate and automatically to switch into a non-AV synchronous mode of pacing. This pacemaker was implanted in 12 patients who had undergone radiofrequency ablation of the A V junction in order to cure severely symptomatic, drug refractory, paroxysmal atrial fibrillation. In an acute, intrapatient comparison between the standard AV synchronous mode and the automatic switching mode, ventricular tracking of atrial fibrillation occurred in 35% and 4% of total beats at rest and in 24% and 2% of total beats during exercise, respectively (P < 0.001). During 5 ± 4 months of follow-up, no further tachyarrhythmia related symptoms occurred. In conclusion, the standard DDDR mode is unable to eliminate ventricular tracking of atrial fibrillation, thus undermining the efficacy of AV junction ablation therapy. The automatic switching mode eliminates this adverse effect of dual chamber pacing.     

Clinical Interest of a Sensor Driven Algorithm Limiting Ventricular Pacing Rate During Supraventricular Tachycardia in Dual Chamber Pacing

A sensor driven algorithm limiting ventricular pacing rate during supraventricular tachycardia (SVT) is included in a dual chamber rate modulated pacemaker sensitive to acceleration forces (Relay, 294-03, Intermedics Inc.). According to the intensity of concomitant exercise, the ventricular pacing rate is limited either to the programmed maximum pacing rate (MPR) or to an interim lower limit, called "conditional ventricular tracking limit" (CVTL). The MPR prevails over the CVTL when the sensor calculated pacing rate exceeds the minimal rate by more than 20 beats/mm. The purpose of the study is to determine the clinical safety and efficacy of this algorithm in patients with intermittent SVT. Method: a Relay was implanted in four patients with a bradycardia/tachycardia syndrome and in four patients with complete atrioventricular block (CAVB). All had episodes of paroxysmal atrial tachycardia. The units were programmed in DDDR: rate responsive parameters were adjusted by simulating the rate response during three levels of exercise to let the MPR override the CVTL only during strenuous exercise. Holter monitors and exercise testings were performed at 3-month follow-up. Results: in seven patients, Holter recordings showed Supraventricular arrhythmias at rest with a ventricular pacing rate limited to the CVTL. Appropriate rate increases during exercise testings were also demonstrated. Three devices had to be reprogrammed in DDIR tone patient suffering from nearly permanent atrial flutter and two patients not tolerating the CVTL pacing rate at rest). Conclusion: the CVTL algorithm is effective in protecting against high ventricular pacing rates during Supraventricular arrhythmias. It allows the selection of the DDDR mode even with a high MPR in patients with intermittent SVT.     

Comparative Evaluation of Bipolar Atrial Electrogram Amplitude During Everyday Activities: Atrial Active Fixation Versus Two Types of Single Pass VDD/R Leads

Endocardial P wave amplitude (PWA) is an important determinant of the atrial sensing capabilities of an atrial-based pacing system. Although changes in PWA during physical activities are known to occur in DDD/R pacing, there is little information on the P wave stability in single pass lead VDD/R pacemakers using floating P wave sensing. We investigated the variation of PWA during daily life activities using telemetry recorded atrial electrograms in 21 patients with DDDR pacemakers (Relay or Elite) and 29 patients with single lead VDD/ R pacemakers (Unity or Thera). Physical activities resulted in marked individual variability of PWA but, as a group, there was no significant difference between PWA during sitting, standing, lying down, and coughing in both DDDR and VDD/R pacing. In the Elite II pacemaker, walking at 2 miles per hour resulted in significant reduction of PWA (11.6% compared with sitting, P < 0.05). The most consistent reduction in PWA occurred in the relaxation phase of the Valsalva maneuver (VM), with all pacemakers showing a reduction in PWA (mean reduction in PWA compared with sitting in DDDR and VDD/R were 16.6% and 12.8%, respectively). Two patients with DDDR pacemakers (Relay) and three patients with VDD/R pacemakers (1 Unity and 2 Thera) had atrial sensing failure during VM or walking. In conclusion, large variation in PWA occurs during daily life activities. The extent of variation is dependent on the patients, types of atrial lead, and the maneuvers performed. A twice sensing threshold may be insufficient to ensure adequate atrial sensing during these activities. The VM, which effects a consistent change in intracardiac volume, is the most reliable method for bedside evaluation of the lower end of sensitivity margin.     

Eccentricities of dual chamber implantable pacemakers

The consequences of a short 160 ms postventricular atrial refractory period (PVARP) were studied in 27 patients with Medtronic Elite series of pacemakers (programmed to the unipolar mode) by using chest wall stimulation and myopotential interference. Because the ventricular refractory period is nonprogrammable at 230 ms, appropriately timed signals produced As-Vr combinations where As is an atrial sensed event and Vr is a ventricular event detected in the ventricular refractory period. The As-Vr combination inhibited the release of the atrial stimulus at the completion of the atrial escape interval in the DDI, DDIR, DDD, and DDDR modes. A paced ventricular beat (Vp) was documented to initiate automatic PVARP extension in circumstances where Vp was preceded by a Vr event and the pacemaker interpreted the Vr-Vp sequence as 2 ventricular events without an intervening atrial event and Vp as a ventricular premature beat. Knowledge of these eccentricities should facilitate the interpretation of complex pacemakers responses to interference.     

A prospective randomized-controlled trial of ventricular fibrillation detection time in a DDDR ventricular defibrillator. Ventak AV II DR Study Investigators

Implantable cardioverter defibrillators (ICDs) with dual chamber and dual chamber rate responsive pacing may offer hemodynamic advantages for some ICD patients. Separate ICDs and DDDR pacemakers can result in device to device interactions, inappropriate shocks, and underdetection of ventricular fibrillation (VF). The objectives of this study were to compare the VF detection times between the Ventak AV II DR and the Ventak AV during high rate DDDR and DDD pacing and to test the safety of dynamic ventricular refractory period shortening. Patients receiving an ICD were randomized in a paired comparison to pacing at 150 beats/min (DDD pacing) or 175 beats/min (DDDR pacing) during ICD threshold testing to create a "worst case scenario" for VF detection. The VF detection rate was set to 180 beats/min, and VF was induced during high rate pacing with alternating current. The device was then allowed to detect and treat VF. The induction was repeated for each patient at each programmed setting so that all patients were tested at both programmed settings. Paired analysis was performed. Patient characteristics were a mean age of 69 +/- 11 years, 78% were men, coronary artery disease was present in 85%, and a mean left ventricular ejection fraction of 0.34 +/- 0.11. Fifty-two episodes of VF were induced in 26 patients. Despite the high pacing rate, all VF episodes were appropriately detected. The mean VF detection time was 2.4 +/- 1.0 seconds during DDD pacing and 2.9 +/- 1.9 seconds during DDDR pacing (P = NS). DDD and DDDR programming resulted in appropriate detection of all episodes of VF with similar detection times despite the "worst case scenario" tested. Delays in detection may be seen with long programmed ventricular refractory periods which shorten the VF sensing window and may be avoided with dynamic ventricular refractory period shortening.     

Initial Experience with Mode Switching in a Dual Sensor, Dual Chamher Pacemaker in Patients with Paroxysmal Atrial Tachyarrhythmias

Mode switching algorithms have been developed to avoid tracking of atrial fibrillation (AF) or flutter (AFL) during DDD(R) pacing. Upon recognition of AF or AFL, the mode is switched to a nontracking, sensor driven mode. The Vitatron Diamond model 800 pacemaker does this on a beat-to-beat basis. Atrial events occurring within a “physiological range” (± 15 beats/min) calculated from a running average of the atrial rate are tracked. When atrial events are not tracked the escape interval is either determined by the sensor(s) or by a fallback algorithm thereby preventing large increases in V-V interval during mode switching. Loss of atrioventricular (AV) synchrony by atrial premature beats and after an episode of AF or AFL is prevented by atrial synchronization pulses (ASP), which are delivered after a safe interval (timed out from the sensed premature atrial event) has expired and before delivery of the next ventricular stimulus. We implanted 26 such devices in 18 men and 8 women with symptomatic second- or third-degree AV block and paroxysmal AF or AFL. Their ages ranged from 18–84 years (mean 60), and the follow-up ranged from 2–13 months (mean 8). During pacemaker check-up, exercise testing or 24-hour Holter monitoring one or more episodes of mode switching was documented in 8 patients. In these 8 patients a smooth transition (ventricular rate) from sinus rhythm to AF or AFL was documented on one or more occasions, without inappropriate increase in ventricular rate in the DDDR mode. None of the patients complained of palpitations. Appropriate rate response was seen in all patients during Holter monitoring and exercise. Restoration of AV synchrony with ASP was documented many times. In 2 patients the DDIR mode was programmed due to intermittent synchronization of ventricular stimuli to near incessant supraventricular tachycardia, which sometimes gave rise to asymptomatic slightly irregular ventricular paced rhythms below WO beats/min. Recognition of AF or AFL was reliable. No inappropriate increases in ventricular pacing rate were seen at the onset of or during AF or AFL. ASP is an effective method of maintaining AV synchrony and avoiding competitive atrial pacing.     

Initial Experience with a New Algorithm for Automatic Mode Switching from DDDR to DDIR Mode

Implantation of dual chamber devices in patients with paroxysmal atrial tachyarrhythmias who require permanent pacemakers may lead to significant complications due to an inappropriately triggered ventricular response. VVI/VVIR units cause loss of AV synchrony in the presence of sinus activity. A new DDDR device (THERA DR, model 7940), with an automatic mode switching (AMS) algorithm, was evaluated. When the mean atrial rate is > 182 beats/min, atrial tachyarrhythmia is detected, and AMS is activated. Twenty-three patients (12 males, mean age 71 ± 7 years) underwent implantation of a THERA DDDR device with the AMS algorithm. Seventeen patients had AV block and/ or sick sinus syndrome (SSS) and atrial arrhythmias, and 6 patients (2 with hypertrophic obstructive cardiomyopathy) had SSS and paroxysmal atrial fibrillation (PAF). The follow-up period was from 1–9 months. During follow-up, Holter monitoring and treadmill tests were performed. Results : Eighty-seven episodes of AMS were recorded. Telemetered AMS recordings demonstrated episodes in which the DDDR mode switched to the DDIR mode in the presence of PAF, and reverted to DDDR when sinus rhythm returned. Paroxysmal supraventricuiar arrhythmias with a heart rate < 182 beats/min did not activate tbe mode switch. Conclusions : This early, short-term clinical experience with a DDDR device capable of AMS from DDDR to DDIR demonstrated appropriate clinical function and response to PAF. These preliminary results suggest that DDDR pacemakers with AMS to DDIR may significantly extend the current indications for dual chamber pacing.     

Modification of the DDD Pacing Mode to Prevent Junctional Reentry Tachycardia: Computer Modelling Experiments

This paper examines the possibility of using short atrioventricular (AV) delay dual chamber pacing to prevent junctional reentry tachycardia mediated by an accessory pathway or by an intra-AV nodal circuit. For this purpose, a clinically realistic computer simulation model of cardiac rhythm and heart-pacemaker interactions has been used. The computational experiments compared the actions of two pacemaker models: (A) a clinically realistic DDD mode operating with quasi-Wenckebach prolongation of the AV delay; and (B) a new modification of the DDD mode introducing independent counters for the atrial and ventricular refractory periods of the heart, and the possibility of instantaneous or shortly delayed atrial pacing triggered by a sensed or paced ventricular event. The pathological phenomena modelled in the experiments simulate different possibilities of tachycardia initiation. These disorders include: (1) single atrial premature beats (APBs), (2) salvos of APBs, (3) closely coupled pairs of APBs, (4) ventricular premature beats initiating an antidromic reentry tachycardia, and (5) ventricular ectopic beats initiating an AV nodal reentry tachycardia. The computational results prove that many possible mechanisms of initiation of junctional reentry tachycardia are beyond the prophylactic capabilities of current sophisticated DDD pacemakers (A). The results also show that the suggested pacing mode (B) improves anti-tachycardia prophylaxis even when responding to complex pathological episodes of the natural cardiac activity. Future development of the suggested mode (B) is discussed.     

Plasma brain natriuretic peptide as a biochemical marker for atrioventricular sequence in patients with pacemakers

We hypothesized that plasma brain natriuretic peptide, like plasma atrial natriuretic peptide, may reflect hemodynamic changes elicited by different cardiac pacing modes. The aim of this study was to investigate whether plasma brain natriuretic peptide could be influenced by different pacing modes or electrical stimulation. The subjects consisted of 164 patients with permanent pacemakers (52 VVI, 30 AAI, 82 DDD pacemakers) and unimpaired heart function. Patients with atrial fibrillation or spontaneous beats were excluded. Plasma atrial natriuretic peptide and brain natriuretic peptide levels were measured at a rate of 70 beats/min after 45 minutes in the supine position. Under ECG monitoring, the pacing mode was switched from DDD to VVI in 12 patients and from DDD to AAI in 4 patients with a dual chamber pacemaker. Plasma atrial natriuretic peptide and brain natriuretic peptide levels were also measured 30 minutes, 60 minutes, and 1 week after mode switching. Plasma atrial natriuretic peptide and brain natriuretic peptide levels were significantly higher in the nonphysiological pacing group than in the physiological pacing group, whereas these values were similar in the DDD and AAI pacing groups. One week after switching from DDD to VVI, plasma atrial natriuretic peptide and brain natriuretic peptide levels were significantly increased, however no significant changes were observed after switching to AAI. Based on a multivariate regression analysis of noninvasive clinical parameters, only a low plasma brain natriuretic peptide was significantly correlated with physiological pacing. We conclude that: (1) plasma brain natriuretic peptide, like atrial natriuretic peptide, is influenced by the pacing mode, but is not influenced by electrical stimulation; and (2) low plasma brain natriuretic peptide is important in relation to physiological pacing.     

Rate Augmentation and Atrial Arrhythmias in DDDR Pacing

SPENCER, W.H., ET AL.: Rate Augmentation and Atrial Arrhythmias in DDDR Pacing. Dual chamber, rate-modulated pacemakers provide the capability of augmenting the heart rate of patients with chronotropic incompetence but also may cause atrial arrhythmias because of high rate, competitive atrial pacing. We studied ten patients with two consecutive 24-hour Holter monitors during which they were alternately programmed to either DDD or DDDR pacing in random order. Maximum heart rates (max HR) were measured at every 15-minute interval during each 24-hour period. DDDR pacing showed rate augmentation, 80 ± 7 average max HR when compared with DDD pacing, average max HR 76 ± 5. These results were even more striking when waking hours (7 am to 10 pm) were compared: average max HR 86 ± 7 DDDR versus 78 ± 4 average max HR DDD. Several patients showed marked rate augmentation. Seven of ten patients preferred DDDR pacing over DDD pacing. In the entire population, DDDR pacing did not result in an increased number of atrial arrhythmias (1.25 atrial events 124 hour) when compared to DDD pacing (1.75 atrial events/ 24 hour). We conclude that DDDR pacing provides heart rate augmentation during daily life in a clinical population while not resulting in a significant increase in atrial arrhythmias. (PACE, Vol. 13, December, Part 11, 1990)     

Impaired Activity Rate Responsiveness of an Atrial Activity-Triggered Pacemaker: The Role of Differential Atrial Sensing in its Prevention

The physiological benefit of rate responsive, single-chamber cardiac pacing is well documented. We studied the activity response of nine atrially placed Activitrax II pacemakers. Seven patients were noted to have an inadequate activity-rate response with maximal pacing rates of 85 to 101 beats/min. Marker Channel analysis revealed that the upper rate timeout was reset by far-field R wave sensing, even when sensing occurred in the atrial refractory period. These 9 pacemakers were tested by atrial sensitivity adjustment for ability to exclude far-field R wave sensing, while preserving P wave sensing. Unipolar implantation data were then examined for predictors of this differential far-R and P-wave sensing. Differential atrial sensing occurred in 4/9 pacemakers (2/2 bipolar in the right atrial appendage; 0/1 bipolar in the coronary sinus; and 4/9 unipolar). An empirically developed index utilizing unipolar implant parameters discriminated outcomes for 8/9 unipolar pacemakers. We conclude that: (1) the rate responsiveness of the atrial Activitrax II pacemaker is limited by far-field R wave sensing even when this occurs during atrial channel refractoriness; (2) reprogramming atrial sensitivity to differentially sensed P and far-field R waves may restore appropriate rate responsiveness; and (3) although a unipolar implant discriminant index may correctly identify adequacy of future rate responsiveness, the atrial application of the Activitrax II pacemaker is cautioned until further validation is forthcoming, particularly when used in unipolar and coronary sinus applications.     

Apparent P Wave Underselling in a DDD Pacemaker Post Exercise

Wencke-bach behavior of DDD pacemakers occurring when the P-P interval varies between the programmed upper rate interval and the total atrial refractory period is symmetrical in a sense that the pacemaker response during atrial rate acceleration is similar to the pacemaker response during atrial rate deceleration. This phenomenon can be observed in all patients with persistent AV block in whom a DDD pacemaker is implanted, during exercise testing when the spontaneous atrial rate exceeds the selected upper rate, i.e., the programmed upper rate interval. However, this phenomenon will not be observed in all patients with intermittent intact AV conduction during exercise. In this case report we describe a patient who showed an asymmetrical response during a bicycle exercise test. There was 1:1 atrial sensing ventricular pacing until the atrial rate exceeded the upper rate of 140 ppm, while atrial sensing was restored during recovery when the conducted sinus rhythm had decreased to 105 beats/min.     

Evaluation of the early hemodynamic changes in carotid arteries during ventricular and dual chamber pacing

In spite of a wide choice of pacemakers, there are some problems in making more rational clinical decisions for individual patients since mode selection and programming is usually performed on the basis of a clinical hunch. The aim of this study was to measure the differences in carotid flow in patients with a pacemaker programmed in the dual chamber and in the single chamber pacing modes. Sixty patients with implanted bipolar DDD pacemakers were enrolled in this study. Blood peak systolic velocity (PSV) and end-diastolic velocity (EDV), cross-sectional area, resistive index (RI), and pulsatility index (PI) were measured in the common (CCA), internal (ICA), and external (ECA) carotid arteries before pacemaker implantation and after dual chamber and ventricular pacing at 60 beats/min. PSVs in the left CCA (79.3 +/- 24.9 cm/s) and right CCA (84.1 +/- 18.7) were shown to significantly decrease after VVI pacing (60.1 +/- 16.6 and 62.1 +/- 20.0, respectively). There was also a similar significant decrease in PSV in the left and right ICAs and ECAs. Besides PSV, RI, and PI in the left and right CCAs, ICAs, and ECAs significantly decreased after VVI pacing. There was no similar decrease after DDD pacing. Cross-sectional area and flow volume in the CCA, ICA, and ECA were similar after DDD and VVI pacing and before pacemaker implantation suggesting that cardiac output was similar when the measurements were recorded. Carotid artery PSVs, pulsatility, and RIs were found to be significantly decreased during VVI pacing compared to baseline and DDD pacing. The greater incidence of adverse cerebral outcomes in patients with VVI rather than DDD pacing may be partly due to decreased carotid PSVs.     

Sensor-Driven Rate Smoothing in a DDDR Pacemaker

DDD pacemakers may have large cycle-to-cycle variations in rate at the upper rate limit because of 2:1 block or Wenckebach-type block. Rate smoothing was introduced as an option to eliminate these large variations. Now, DDDR pacemakers can produce similar electrocardiographic displays through a different mechanism that uses an activity sensor. This is termed "sensor-driven rate smoothing" because it occurs only when the activity sensor is driving the pacemaker. In the case described, as the atrial rate exceeded the maximum tracking rate and reverted to Wenckebach-type block, the RR interval varied only from 600 msec to 680 msec (13.3% rate-smoothing value) because of sensor-driven pacing. Maximal sensor-driven rate smoothing requires optimal programming of the rate response indicators. This sensor-driven rate-smoothing effect is an electrocardiographic manifestation that will undoubtedly be seen more frequently as DDDR devices come into widespread clinical use.